Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Survival nomograms for stage III colorectal cancer

View through CrossRef
Abstract The postoperative survival of patients with stage III colorectal cancer (CRC) various obviously. We sought to develop novel nomograms for predicting the survival of these patients after radical surgery and postoperative chemotherapy. A total of 620 consecutive patients with stage III CRC who underwent curative resection and postoperative chemotherapy between January 2009 and December 2015 were retrospectively collected and randomly allocated to the training (n = 372) or validation cohort (n = 248). Clinicopathological factors were collected and analyzed. On the basis of data from 372 patients in the training set, predictive factors for overall survival (OS) and disease-free survival (DFS) were identified using multivariate Cox regression and used to construct nomograms. The predictive performance of the nomograms was assessed by concordance index (C-index) and calibration plots. An external cohort of 248 patients was used to validate the nomograms. Furthermore, nomogram performance was compared with the performance of T and N stage stratification. Tumor differentiation grade, lymph node metastasis ratio, intravascular emboli (IVE), preoperative serum carcinoembryonic antigen (CEA) level, albumin to globulin ratio (AGR), T stage and N stage were significant prognostic factors for OS on multivariate analysis; whereas, Tumor differentiation grade, lymph node metastasis ratio, IVE, AGR and N stage were significant for DFS. Nomograms to predict 3- and 5-year OS and DFS were established that performed well (C-indexes of 0.734 [95% CI, 0.691–0.779] for OS and 0.699 [95% CI, 0.657–0.740] for DFS prediction), and nomogram accuracy was confirmed in the validation cohort. Furthermore, model comparison proved that the nomograms were superior to risk stratification by T and N stage for stage III CRC. We propose 2 practical nomograms for stage III CRC patients that provide more accurate prognostic predictions and should be helpful for guiding individualized treatment and postoperative surveillance.
Title: Survival nomograms for stage III colorectal cancer
Description:
Abstract The postoperative survival of patients with stage III colorectal cancer (CRC) various obviously.
We sought to develop novel nomograms for predicting the survival of these patients after radical surgery and postoperative chemotherapy.
A total of 620 consecutive patients with stage III CRC who underwent curative resection and postoperative chemotherapy between January 2009 and December 2015 were retrospectively collected and randomly allocated to the training (n = 372) or validation cohort (n = 248).
Clinicopathological factors were collected and analyzed.
On the basis of data from 372 patients in the training set, predictive factors for overall survival (OS) and disease-free survival (DFS) were identified using multivariate Cox regression and used to construct nomograms.
The predictive performance of the nomograms was assessed by concordance index (C-index) and calibration plots.
An external cohort of 248 patients was used to validate the nomograms.
Furthermore, nomogram performance was compared with the performance of T and N stage stratification.
Tumor differentiation grade, lymph node metastasis ratio, intravascular emboli (IVE), preoperative serum carcinoembryonic antigen (CEA) level, albumin to globulin ratio (AGR), T stage and N stage were significant prognostic factors for OS on multivariate analysis; whereas, Tumor differentiation grade, lymph node metastasis ratio, IVE, AGR and N stage were significant for DFS.
Nomograms to predict 3- and 5-year OS and DFS were established that performed well (C-indexes of 0.
734 [95% CI, 0.
691–0.
779] for OS and 0.
699 [95% CI, 0.
657–0.
740] for DFS prediction), and nomogram accuracy was confirmed in the validation cohort.
Furthermore, model comparison proved that the nomograms were superior to risk stratification by T and N stage for stage III CRC.
We propose 2 practical nomograms for stage III CRC patients that provide more accurate prognostic predictions and should be helpful for guiding individualized treatment and postoperative surveillance.

Related Results

Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Diagnostic nomogram for distant metastasis in newly diagnosed colorectal cancer based on clinical features
Diagnostic nomogram for distant metastasis in newly diagnosed colorectal cancer based on clinical features
Abstract Background Colorectal cancer is one of the most common primary malignancies and the third most common cause of cancer death in both men and women in the United St...
A Novel Nutrition-Based Nomogram to Predict Prognosis After Curative Resection of Gastric Cancer
A Novel Nutrition-Based Nomogram to Predict Prognosis After Curative Resection of Gastric Cancer
Objective: We sought to investigate the prognostic significance of body composition and weight change during the first 6 months of adjuvant chemotherapy after R0 resection and deve...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
Data from TIPE Inhibits Ferroptosis in Colorectal Cancer Cells by Regulating MGST1/ALOX5
Data from TIPE Inhibits Ferroptosis in Colorectal Cancer Cells by Regulating MGST1/ALOX5
<div>Abstract<p>TIPE is a protein highly expressed in various cancers that promotes ferroptosis in colorectal cancer cells. Ferroptosis is a nonapoptotic cell death cau...
Data from AFDN Deficiency Promotes Liver Tropism of Metastatic Colorectal Cancer
Data from AFDN Deficiency Promotes Liver Tropism of Metastatic Colorectal Cancer
<div>Abstract<p>Liver metastasis is a major cause of morbidity and mortality in patients with colorectal cancer. A better understanding of the biological mechanisms und...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose: To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...

Back to Top